Efficacy and Safety of Eight Classes of Glucose-Lowering Agents as Monotherapy for Type 2 Diabetes: A Systematic Review and Indirect Treatment Comparison

SSRN Electronic Journal ◽

10.2139/ssrn.3539644 ◽

2020 ◽

Author(s):

Shuyan Gu ◽

Xueshan Sun ◽

Xiaoqian Hu ◽

Lizheng Shi ◽

Minzhuo Huang ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Glucose Lowering ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment

Download Full-text

Comparative Efficacy and Safety of Glucose-Lowering Drugs as Monotherapy for Type 2 Diabetes: A Systematic Review and Indirect Treatment Comparison

SSRN Electronic Journal ◽

10.2139/ssrn.3918870 ◽

2021 ◽

Author(s):

Shuyan Gu ◽

Xiaoqian Hu ◽

Xuemei Zhen ◽

Lizheng Shi ◽

Xueshan Sun ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Glucose Lowering ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment

Download Full-text

Review for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v1/review3 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v2/review1 ◽

2020 ◽

Author(s):

Viral Shah

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon‐like peptide‐1 receptor agonists: a systematic literature review and indirect treatment comparison

Diabetes Obesity and Metabolism ◽

10.1111/dom.14136 ◽

2020 ◽

Vol 22 (11) ◽

pp. 2170-2178 ◽

Cited By ~ 1

Author(s):

Philip D. Home ◽

Vanita R. Aroda ◽

Lawrence Blonde ◽

Patricia Guyot ◽

Alka Shaunik ◽

...

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v1/review1 ◽

2020 ◽

Author(s):

Viral Shah

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v2/review3 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Author response for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v2/response1 ◽

2020 ◽

Author(s):

Philip D. Home ◽

Vanita R. Aroda ◽

Lawrence Blonde ◽

Patricia Guyot ◽

Alka Shaunik ◽

...

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Decision letter for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Decision letter for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists (GLP-1RAs): a systematic literature review and indirect treatment comparison"

10.1111/dom.14136/v1/review2 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text